Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates.

Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.

Dynavax Technologies has revealed promising topline outcomes from the initial part of its Phase I/II clinical trial, ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

As an award-winning actress in films like What’s Love Got to Do With It, Malcolm X, Waiting to Exhale and Black Panther, ...

A crunchy twist on a classic, stacking chips inside a sandwich for extra flavor and texture. Would you try this combo?

A significant figure in the Australian film industry, recognised internationally for his surf and underwater cinematography, ...

The Nigerian government has reduced the cost of dialysis for kidney patients from N50,000 to N12,000 per session at federal ...

Shares in Dynavax Technologies Corporation closed 5% higher Thursday after the presentation of positive top-line results from ...

A planning application for a retrofit-led regeneration of the former GSK headquarters has been submitted, outlining a new ...

Mukherjee brings over 18 years of experience in digital strategy, e-commerce, and brand management, including leadership ...

ESPN Offers Critical Take on 49ers' Trade for Brian Robinson Jr.